More specifically, four gene mutations (LRP1B, MLH1, EPHA5, and NTRK2) were only present in the NSCLC coexisting COPD group, which was not true for the NSCLC alone group. This evidence concerns the gene EPHA5 and non-small cell lung carcinoma.